Does ATEZOLIZUMAB Cause Malignant neoplasm progression? 238 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 238 reports of Malignant neoplasm progression have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.7% of all adverse event reports for ATEZOLIZUMAB.
238
Reports of Malignant neoplasm progression with ATEZOLIZUMAB
0.7%
of all ATEZOLIZUMAB reports
118
Deaths
89
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ATEZOLIZUMAB?
Of the 238 reports, 118 (49.6%) resulted in death, 89 (37.4%) required hospitalization, and 10 (4.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 238 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ATEZOLIZUMAB Alternatives Have Lower Malignant neoplasm progression Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN